Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

We need rapid tests for a fast virus

Raghav Gupta, MD
Conditions
August 12, 2020
Share
Tweet
Share

Imagine a future where you wake up, go to the bathroom, pick up a small strip of paper, and put it in a tube with your saliva and saline.  By the time you are done with part of your morning routine, within 15 minutes or so, the paper will tell you if that morning, you are positive for the novel coronavirus or not.

And you can do that randomly on any occasion.  Your employer can do that.  Schools and colleges can do that regularly in a predetermined fashion.

And what if it costs a dollar to do that each time?  I seriously doubt we would be spreading the virus as ubiquitously as we are doing now.

That future can exist today, but with FDA, CDC, and the government’s backing.

Why do we need a fast and cheap at-home test?

My opening paragraph partially answers this question.  Besides that, the CDC currently estimates we are missing 90 percent of infections.  Our current testing methodology and its bottlenecked throughput are surely not helping.  And a large chunk of what we are diagnosing is relatively ineffectual in terms of attempting to contain the pandemic as we don’t know the result for many days.  For many, the point of the test is to be able to quarantine or not, and that is missed vehemently.

How do they work?

Fast tests are antigen tests.  They are qualitative tests and utilize lateral flow assay technology, the same way as home pregnancy tests.

Not to be confused with the highly sensitive rapid PCR tests approved earlier this year from Abbott and Cepheid, which can also give results in less than 30 minutes.  PCR testing principle is based on viral RNA amplification and requires laboratory personnel and equipment.  It can also remain positive for a longer duration even after the patient recovers and may not correlate with infectivity per se.

Antigen tests are based on finding the infective antigen, the spike protein responsible for creating a doorway into human cells.  These tests use antigen and antibody binding to give the results.  They are inexpensive to produce, and in most cases, conveniently, saliva can be used as a testing substrate, and usually, no special education is required to conduct such testing.

Accuracy?

So they are not very accurate.  Stay with me, though.  Experts believe they will still be significantly better than what we are doing right now.

Antigen tests are less sensitive, often resulting in a negative result when the virus is actually present.  This can happen in the initial phases of infection when the viral titers and, therefore, the antigen protein levels are below the test’s limit of detection.  As the virus counts increase and the infectivity grows due to higher antigen count, these tests become positive.  Consequently, their specificity is much higher, meaning fewer (but not zero) false positives.

It may be what works in our favor.  Viral transmission in COVID-19 is at its peak when the viral load is highest.  Often, that is at the pre-symptomatic phase of infection.  Ergo, these fast antigens tests should detect the infection when it really matters; when the risk of spread is highest.

Currently available PCR tests can work too, but if the results are not back for days, they miss the most infectious period, rendering them mostly futile.  While the accuracy of PCR tests is critical in a hospital setting, analysis and modeling studies have suggested that even a test that is less sensitive (greater than 70 percent) can be enough, if it can be repeated regularly, to mitigate the spread of SARS-CoV2.  Schools and jobs with close proximity working environments such as meat factories can be benefitted the most.

ADVERTISEMENT

Then why the delay?

The rate-limiting step is the regulatory process.  FDA requires the tests to be close to the analytical sensitivity of the PCR tests, or at least 80 percent, which is in good faith to diagnose COVID-19.  But to diagnose the presence of the virus, and from a public health perspective, a cheap, quick, and repeatable test with a lower sensitivity can make do.

Some fast antigen tests are available and approved.  Quidel and Becton Dickinson recently received FDA approval for rapid testing for recurrent testing in a nursing home or physician office setting as it still requires some laboratory equipment.  Governors of seven states (Maryland, Louisiana, Massachusetts, Michigan, Ohio, Virginia, and North Carolina) have announced a bipartisan agreement to buy such 500,000 fast antigen tests per state for widespread testing expansion for places such as schools, workplaces, and nursing homes.

Another low-cost rapid PCR test, a 2-hour SalivaDirect test, is hoping to get FDA approval soon.  It uses commonly available ingredients in any lab and hence hopefully can be readily scalable for SARS-CoV2 surveillance.

An NIH supported $1.5 billion dollars federal initiative called RADx is helping to develop rapid tests, but the process still requires higher accuracy.  A non-profit organization is also hosting a 6-month competition to develop faster and cheaper tests.  The finalists will be declared in October of 2020.  The pilot phase of test deployment and grand prize winners (totaling $5 million) announcement is slated for January 2021.

Epilogue 

Michael Mina, at the Harvard T.H. Chan School of Public Health, reports that small companies such as E25Bio and Sherlock Biosciences can deliver such fast home-tests.  He suggests that if the federal government backs the effort, the manufacturing and application can be achieved at a rapid pace.  Grassroots level support by the population at large can help deliver the knowledge.

America has the highest number of COVID-19 cases than any other country in the world.  We need fast tests (those that can be done frequently by anyone with minimal cost and can give results in a few minutes rather than a few days) for a fast virus (which can spread unchecked at an exponential speed without quarantine due to delays in diagnosis).

And we need them now.

Raghav Gupta is an interventional cardiologist.

Image credit: Shutterstock.com

Prev

Lifelong learning through skillful self-reflection

August 12, 2020 Kevin 0
…
Next

The success of a COVID-19 vaccine depends on effective scientific communication

August 12, 2020 Kevin 0
…

Tagged as: COVID, Infectious Disease

Post navigation

< Previous Post
Lifelong learning through skillful self-reflection
Next Post >
The success of a COVID-19 vaccine depends on effective scientific communication

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Raghav Gupta, MD

  • Trained immunity in the fight against COVID

    Raghav Gupta, MD
  • Opening schools? The devil is in the details. 

    Raghav Gupta, MD
  • Complacency fuels the slow burn of COVID-19

    Raghav Gupta, MD

Related Posts

  • Beware of food sensitivity tests on Facebook

    Roy Benaroch, MD
  • Rapid changes to AOA inclusion are inequitable

    Jose-Marc Techner
  • Medicine, fast and slow

    Claire Brown
  • Is misinformation deadlier than the virus?

    Michele Luckenbaugh
  • Health care professionals who fast and celebrate the month of Ramadan

    Nasir Malim, MD, MPH
  • Does Chicago needs a rapid response to food sanitation and safety?

    Janice Phillips, PhD, RN and John Mazzeo, PhD

More in Conditions

  • What if medicine had an exit interview?

    Lynn McComas, DNP, ANP-C
  • Finding healing in narrative medicine: When words replace silence

    Michele Luckenbaugh
  • Why coaching is not a substitute for psychotherapy

    Maire Daugharty, MD
  • Why doctors stay silent about preventable harm

    Jenny Shields, PhD
  • Why gambling addiction is America’s next health crisis

    Safina Adatia, MD
  • How robotics are reshaping the future of vascular procedures

    David Fischel
  • Most Popular

  • Past Week

    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • When did we start treating our lives like trauma?

      Maureen Gibbons, MD | Physician
    • Why male fertility needs to be part of every health conversation

      Hoag Memorial Hospital Presbyterian | Conditions
    • How home-based AI can reduce health inequities in underserved communities [PODCAST]

      The Podcast by KevinMD | Podcast
    • Inside human trafficking: a guide to recognizing and preventing it [PODCAST]

      The Podcast by KevinMD | Podcast
    • Graduating from medical school without family: a story of strength and survival

      Anonymous | Education
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • Addressing the physician shortage: How AI can help, not replace

      Amelia Mercado | Tech
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
  • Recent Posts

    • How home-based AI can reduce health inequities in underserved communities [PODCAST]

      The Podcast by KevinMD | Podcast
    • Adriana Smith’s story: a medical tragedy under heartbeat laws

      Nicole M. King, MD | Physician
    • What if medicine had an exit interview?

      Lynn McComas, DNP, ANP-C | Conditions
    • Why U.S. health care pricing is so confusing—and how to fix it

      Ashish Mandavia, MD | Physician
    • From survival to sovereignty: What 35 years in the ER taught me about identity, mortality, and redemption

      Kenneth Ro, MD | Physician
    • When doctors forget how to examine: the danger of lost clinical skills

      Mike Stillman, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • When did we start treating our lives like trauma?

      Maureen Gibbons, MD | Physician
    • Why male fertility needs to be part of every health conversation

      Hoag Memorial Hospital Presbyterian | Conditions
    • How home-based AI can reduce health inequities in underserved communities [PODCAST]

      The Podcast by KevinMD | Podcast
    • Inside human trafficking: a guide to recognizing and preventing it [PODCAST]

      The Podcast by KevinMD | Podcast
    • Graduating from medical school without family: a story of strength and survival

      Anonymous | Education
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • Addressing the physician shortage: How AI can help, not replace

      Amelia Mercado | Tech
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
  • Recent Posts

    • How home-based AI can reduce health inequities in underserved communities [PODCAST]

      The Podcast by KevinMD | Podcast
    • Adriana Smith’s story: a medical tragedy under heartbeat laws

      Nicole M. King, MD | Physician
    • What if medicine had an exit interview?

      Lynn McComas, DNP, ANP-C | Conditions
    • Why U.S. health care pricing is so confusing—and how to fix it

      Ashish Mandavia, MD | Physician
    • From survival to sovereignty: What 35 years in the ER taught me about identity, mortality, and redemption

      Kenneth Ro, MD | Physician
    • When doctors forget how to examine: the danger of lost clinical skills

      Mike Stillman, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

We need rapid tests for a fast virus
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...